UNSPSC 51411608: Tenitramine

This classification denotes an ethylenediamine with the molecular formula C10H20N6O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CKB16BAQ3S, chemically known as n,n,n,n-tetrakis(2-hydroxyethyl)ethylenediaminetetranitrate but generally known as tenitramine, which bears US NIH Compound Identifier 168009. European Medicines Agency schedules Tenitramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15485MIG.

World Health Organization schedules tenitramine in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, TENITRAMINE remains the US FDA Preferred Term for this commodity. SMILES: C(CN(CCO[N+](=O)[O-])CCO[N+](=O)[O-])N(CCO[N+](=O)[O-])CCO[N+](=O)[O-].

UNSPSC 51411608 Tenitramine is a Commodity code covering pharmaceutical active pharmaceutical ingredients and finished medications procured by state and local health agencies, fire rescue departments, and cooperative purchasing organizations. State and local governments buy advanced life support medications, generic multi-source pharmaceuticals, and over-the-counter products under this code, typically through sealed competitive bids and cooperative purchasing agreements that span multiple jurisdictions and authorized wholesaler networks. Issuing bodies include municipal fire rescue services, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across participating state agencies and local government facilities. The scope includes finished pharmaceutical products with specific National Drug Codes (NDCs), packaging specifications, and compliance requirements for Good Manufacturing Practices (cGMP), Drug Supply Chain Security Act (DSCSA), FDA approval, and accessibility standards including Safety Data Sheets compliant with OSHA Hazard Communication Standards.

Recent activity concentrates in Florida and the Upper Midwest, with established multistate cooperative purchasing infrastructure. The City of Tampa's Purchasing Department issued IFB No. 26P00188 for Advanced Life Support Medications to be used by Tampa Fire Rescue, seeking 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with a response deadline of April 8, 2026 and estimated contract value of $40,000.00, with a Small Local Business Enterprise (SLBE) sheltered market designation offering a 5 percent bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP No. S1070000015802 for generic multi-source pharmaceuticals and OTC products distributed to participating state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The Texas Health and Human Services Commission issued RFI No. HHS0017013 on March 27, 2026 to gather market intelligence on direct-to-manufacturer prescription programs, with a response deadline of April 3, 2026, representing early-stage procurement planning rather than a formal competitive solicitation.